Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

816
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
816
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

908
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
908
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Trends, Patterns, and Demographic Dynamics of Drug Resistance in <i>Mycobacterium tuberculosis</i> and Nontuberculous: A Multi-Year Analysis at the National Tuberculosis Reference Laboratory.

Microbial drug resistance (Larchmont, N.Y.)·2026
Same author

Baseline epidemiology study of nasopharyngeal carriage and serotypes of Streptococcus pneumoniae in children aged 6-59 months prior to the introduction of pneumococcal conjugate vaccine in Iran.

Journal of infection and public health·2026
Same author

Comprehensive Approaches to Protein Detection and Analysis in Mycobacterium tuberculosis.

Advances in experimental medicine and biology·2025
Same author

Protein Architecture and Composition in Mycobacterium tuberculosis.

Advances in experimental medicine and biology·2025
Same author

Contribution of Proteins to Membrane and Cell Wall Structures in Mycobacterium tuberculosis.

Advances in experimental medicine and biology·2025
Same author

Protein-Mediated Virulence in Mycobacterium tuberculosis.

Advances in experimental medicine and biology·2025
Same journal

Peptidomics in the Spotlight: Advanced Sample Treatment Techniques and Analytical Insights.

Advances in experimental medicine and biology·2026
Same journal

Methods for the Investigation of Protein-Ligands Interactions.

Advances in experimental medicine and biology·2026
Same journal

Sample Preparation Strategies for Microbial Cell Surface Proteomics: Integrating Shaving and Shotgun Approaches.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Sample Preparation for the Petroleum Industry: A Biocorrosion Case Study.

Advances in experimental medicine and biology·2026
Same journal

Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Analysis of Histone Sequence Variants and Post-translationally Modified Forms.

Advances in experimental medicine and biology·2026
查看所有相关文章

相关实验视频

Updated: Jan 11, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.2K

结核病:一个持续的全球威胁

Parissa Farnia1, Ali Akbar Velayati2, Jalaledin Ghanavi2

  • 1Shahid Beheshti University of Medical Sciences, Mycobacteriology Research Centre (MRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran. farnia@theaasm.org.

Advances in experimental medicine and biology
|November 9, 2025
PubMed
概括
此摘要是机器生成的。

结核病 (TB) 是全球主要的健康威胁,每年有数百万人受到影响. 解决社会经济因素,耐药性和流行病干扰对于消除结核病至关重要.

关键词:
年龄年龄年龄年龄年龄年龄性别 性别 性别 性别影响影响 影响 影响结核病菌菌菌的结核病菌的结核病菌.人口动态 人口动态结核病控制计划 结核病控制计划

更多相关视频

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.6K

相关实验视频

Last Updated: Jan 11, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.2K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.6K

科学领域:

  • 公共卫生 公共卫生
  • 传染性疾病 传染性疾病
  • 全球健康 全球健康

背景情况:

  • 结核病 (TB) 构成了全球严重的健康负担,每年影响数百万人,并导致大量死亡.
  • 高结核病发病率集中在低收入和中等收入国家,由贫困和生活条件差等社会经济因素加剧.
  • 耐药结核病菌株 (MDR-TB,XDR-TB,TDR-TB) 和COVID-19的干扰使治疗和控制工作复杂化,扭转了进展.

研究的目的:

  • 突出结核病 (TB) 持续存在的全球挑战.
  • 强调社会经济决定因素和耐药性对结核病控制的影响.
  • 强调需要全面的战略来实现结核病的消除.

主要方法:

  • 来自世卫组织2024年全球结核病报告的数据分析.
  • 审查导致结核病传播和治疗挑战的因素.
  • 评估COVID-19大流行对结核病服务的影响.

主要成果:

  • 在2023年,有1060万人患有结核病,导致160万人死亡.
  • 社会经济因素和耐药结核病菌株显著恶化了结果,增加了成本.
  • COVID-19 流行病对结核病例检测和治疗连续性产生了负面影响.

结论:

  • 协调,多部门战略对于消除结核病至关重要.
  • 解决社会经济障碍,改善诊断和打击耻辱是非常重要的.
  • 投资研究新的预防和治疗工具至关重要,以实现世卫组织结核病终结战略的目标.